查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1629270

护理点传染病检测市场，按技术、按疾病、按最终用户、按国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Point of Care Infectious Disease Testing Market, By Technology, By Disease, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，即时传染病检测市场规模为 114.0943 亿美元，2024 年至 2032 年复合年增长率为 4.69%。

即时传染病检测市场-市场动态

传染病发病率的上升预计将推动市场的成长。

随着流感、COVID-19、HIV、肝炎和性传染病等传染病发病率的上升，对快速且易于使用的检测解决方案的需求也增加。 POC 测试可及时提供结果，有助于立即做出治疗决定。根据国家生物技术资讯中心的数据，传染病仍然是全世界发病和死亡的主要原因之一，全世界每年有超过 5,200 万人 (33%) 死亡。此外，对快速检测的需求不断增长可能为市场创造成长机会。然而，对某些 POC 测试的准确性和可靠性的担忧可能会阻碍市场成长。

即时护理传染病检测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.69% 左右的复合年增长率成长

基于技术细分，预计分子诊断将在 2023 年呈现最大市场份额

根据疾病细分，COVID-19 是 2023 年的主导类型

根据最终用户细分，诊所是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

护理点传染病检测市场-細項分析：

全球护理点传染病检测市场根据技术、疾病、最终用户和地区进行细分。

根据技术，市场分为三个部分：侧流免疫分析、凝集测试、流通测试/免疫浓缩分析、分子诊断和其他。其中，分子诊断在市场上占据领先地位。这部分强调了在患者护理点或附近进行快速、精确的传染病检测的重要性，采用复杂的分子方法，如聚合酶链反应 (PCR) 和下一代定序 (NGS)。

市场依疾病分为两大类：HIV POC、艰难梭菌 POC、HBV POC、肺炎或链球菌相关感染、呼吸道合胞病毒 (RSV) POC、HPV POC、流感/流感 POC、HCV POC、MRSA POC 、结核病及抗药性结核病POC、HSV POC、COVID-19 等。 COVID-19 细分市场在市场上占据主导地位。这场大流行凸显了迅速而精确的检测的迫切必要性，以减轻病毒的传播并加强患者管理。

根据用户，市场分为两个部分：诊所、医院、家庭和自我测试、辅助生活医疗设施和实验室。诊所在市场上占据主导地位。这些设施包括初级护理、紧急护理和专科诊所，能够进行现场测试，从而促进患者管理方面的及时决策，从而获得显着优势。

即时护理传染病检测市场 - 地理洞察

市场地域广阔，涵盖北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些领域根据对商业活动做出贡献的国家进一步细分。北美是市场成长的领先地区，这主要是由于越来越多地采用先进的护理点诊断来识别各种传染病。该地区受益于强大的医疗保健基础设施，促进创新诊断技术的整合。医院、诊所和实验室正在逐步实施即时检测解决方案，以改善病患照护。据美国国家生物技术资讯中心称，截至 2020 年 7 月 13 日，美国已有超过 330 万居民被诊断出患有 2019 年冠状病毒病（COVID-19），报告死亡人数超过 135,000 人。在家庭医疗保健服务需求不断增长的推动下，欧洲成为市场成长的第二大地区。

护理点传染病检测市场-竞争格局：

即时照护 (POC) 传染病检测市场的特征是众多利害关係人之间的激烈竞争，而对快速、精确的诊断解决方案的需求不断增长，加剧了这种竞争。许多公司正在与医疗保健组织和科技企业建立策略联盟，以提高他们的测试能力并扩大他们的市场份额。这种竞争环境是动态的、不断变化的。随着快速、准确诊断的必要性不断升级，公司必须保持敏捷性，以应对不断变化的市场需求和技术创新。

最新进展：

2024年7月29日，罗氏宣布成功完成对LumiraDx的Point of Care技术的收购，并已获得所有必要的反垄断和监管批准。罗氏现在将着手将创新的多检测即时护理平台以及相关的研发、营运和商业设施全面整合到其全球组织中。

目录

第 1 章：即时传染病检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 护理点传染病检测市场技术片段
    • 护理点传染病检测市场片段（依疾病）
    • 最终使用者的护理点传染病检测市场片段
    • 按国家/地区分類的护理点传染病检测市场片段
    • 按地区分類的护理点传染病检测市场片段
  • 竞争洞察

第 3 章：即时护理传染病检测主要市场趋势

  • 即时护理传染病检测市场驱动因素
    • 市场驱动因素的影响分析
  • 即时传染病检测市场限制
    • 市场限制影响分析
  • 即时护理传染病检测市场机会
  • 即时护理传染病检测市场未来趋势

第 4 章：即时传染病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：即时护理传染病检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：即时传染病检测市场格局

  • 2023 年护理点传染病检测市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：即时传染病检测市场 - 依技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 侧流免疫分析
    • 凝集试验
    • 流通测试/免疫浓度测定
    • 分子诊断
    • 其他的

第 8 章：即时传染病检测市场 - 按疾病分类

  • 概述
    • 按疾病分類的细分市场占有率分析
    • 爱滋病毒POC
    • 艰难梭菌 POC
    • 乙肝病毒POC
    • 肺炎或链球菌相关感染
    • 呼吸道合胞病毒 (RSV) POC
    • HPV POC
    • 流感/流感 POC
    • 丙型肝炎病毒POC
    • 耐甲氧西林金黄色葡萄球菌POC
    • 结核病和抗药性结核病 POC
    • 单纯疱疹病毒POC
    • 新冠肺炎
    • 其他

第 9 章：护理点传染病检测市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 诊所
    • 医院
    • 家庭和自我测试
    • 辅助生活医疗设施
    • 实验室

第 10 章：即时护理传染病检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美护理点传染病检测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术）
    • 北美市场规模与预测（按疾病）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲床边传染病检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模与预测（按疾病）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区护理点传染病检测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按疾病）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲即时传染病检测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按疾病）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 护理点传染病检测中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 即时传染病检测产业

  • 竞争仪表板
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • Becton, Dickinson & Company
    • Abbott
    • Thermo Fisher Scientific Inc
    • Chembio Diagnostics Inc.
    • Trinity Biotech
    • Cardinal Health
    • Quest Diagnostics Incorporated
    • Bio-Rad Laboratories Inc.
    • bioMerieux SA
    • Sight Diagnostics Ltd.
    • Gene POC
    • Trivitron Healthcare
    • OJ-Bio Ltd.
    • Ortho-Clinical Diagnostics.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4443

REPORT HIGHLIGHT

Point of Care Infectious Disease Testing Market size was valued at USD 11,409.43 million in 2023, expanding at a CAGR of 4.69% from 2024 to 2032.

Point of Care Infectious Disease Testing (POC IDT) refers to diagnostic tests conducted at or near the site of patient care, allowing for the rapid detection of infectious diseases. This approach enables healthcare providers to obtain immediate results, facilitating timely diagnosis and treatment decisions without the need to send samples to a central laboratory. POC IDT represents a significant progression in healthcare, offering rapid and accessible diagnostic solutions that enhance patient care and contribute positively to public health outcomes.

Point of Care Infectious Disease Testing Market- Market Dynamics

Rising Incidence of Infectious Diseases is expected to drive the growth of the market.

As the prevalence of infectious diseases such as influenza, COVID-19, HIV, hepatitis, and STIs rises, the demand for rapid and accessible testing solutions increases. POC tests provide timely results that facilitate immediate treatment decisions. According to the National Center for Biotechnology Information, Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Furthermore, Growing Demand for Rapid Testing may create growth opportunities for the market. However, Concerns about the accuracy and reliability of some POC tests can hinder market growth.

Point of Care Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.69% over the forecast period (2024-2032)

Based on Technology segmentation, Molecular Diagnostics was predicted to show maximum market share in the year 2023

Based on Disease segmentation, COVID-19 was the leading type in 2023

Based on End-User segmentation, Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Point of Care Infectious Disease Testing Market- Segmentation Analysis:

The Global Point of Care Infectious Disease Testing Market is segmented based on Technology, Disease, End-User, and Region.

The market is classified into three segments according to technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test/Immunoconcentration Assay, Molecular Diagnostics, and Others. Among these, Molecular Diagnostics holds a leading position in the market. This segment emphasizes the importance of swift and precise testing for infectious diseases conducted at or near the point of patient care, employing sophisticated molecular methods such as polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The market is classified into two primary categories based on diseases: HIV POC, Clostridium Difficile POC, HBV POC, pneumonia or Streptococcus-associated infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, COVID-19, and others. The COVID-19 segment holds a dominant position in the market. The pandemic underscored the urgent necessity for swift and precise testing to mitigate the virus's spread and enhance patient management.

The market is categorized into two segments according to the Users: Clinics, Hospitals, Home and Self Testing, Assisted Living Healthcare Facilities, and Laboratories. Clinics hold a dominant position within the market. These facilities, which encompass primary care, urgent care, and specialty clinics, gain significant advantages from the capability to conduct tests on-site, facilitating prompt decision-making regarding patient management.

Point of Care Infectious Disease Testing Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America is the leading region in market growth, primarily due to the rising adoption of advanced point-of-care diagnostics for identifying various infectious diseases. The region benefits from a robust healthcare infrastructure that facilitates the integration of innovative diagnostic technologies. Hospitals, clinics, and laboratories are progressively implementing point-of-care testing solutions to improve patient care. According to the National Center for Biotechnology Information, as of July 13, 2020, over 3.3 million residents in the United States have been diagnosed with coronavirus disease 2019 (COVID-19), with more than 135,000 fatalities reported. Europe ranks as the second-largest region for market growth, driven by an increasing demand for home healthcare services.

Point of Care Infectious Disease Testing Market- Competitive Landscape:

The market for point-of-care (POC) Infectious Disease Testing is marked by significant competition among numerous stakeholders, fueled by the increasing need for swift and precise diagnostic solutions. A variety of companies are engaging in strategic alliances with healthcare organizations and technology enterprises to improve their testing capabilities and broaden their market presence. This competitive environment is dynamic and evolving. As the necessity for rapid and accurate diagnostics escalates, companies must remain agile in responding to shifting market demands and technological innovations.

Recent Developments:

On July 29, 2024, Roche announced the successful completion of its acquisition of LumiraDx's Point of Care technology, having obtained all necessary antitrust and regulatory approvals. Roche will now proceed with the comprehensive integration of the innovative multi-assay point-of-care platform, along with the associated research and development, operational, and commercial facilities, into its global organization.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Becton, Dickinson & Company
  • Abbott
  • Thermo Fisher Scientific Inc
  • Chembio Diagnostics Inc.
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics Incorporated
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Sight Diagnostics Ltd.
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio Ltd.
  • Ortho-Clinical Diagnostics.
  • Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Lateral Flow Immunoassay
  • Agglutination Test
  • Flow-through test/Immunoconcentration Assay
  • Molecular Diagnostics
  • Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • HIV POC
  • Clostridium Difficile POC
  • HBV POC
  • Pneumonia Or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB & Drug-resistant TB POC
  • HSV POC
  • COVID-19
  • Other

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Clinics
  • Hospitals
  • Home and Self Testing
  • Assisted Living Healthcare Facilities
  • Laboratory

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Point of Care Infectious Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Point of Care Infectious Disease Testing Market Snippet by Technology
    • 2.1.2. Point of Care Infectious Disease Testing Market Snippet by Disease
    • 2.1.3. Point of Care Infectious Disease Testing Market Snippet by End-User
    • 2.1.4. Point of Care Infectious Disease Testing Market Snippet by Country
    • 2.1.5. Point of Care Infectious Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Point of Care Infectious Disease Testing Key Market Trends

  • 3.1. Point of Care Infectious Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Point of Care Infectious Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Point of Care Infectious Disease Testing Market Opportunities
  • 3.4. Point of Care Infectious Disease Testing Market Future Trends

4. Point of Care Infectious Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Point of Care Infectious Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Point of Care Infectious Disease Testing Market Landscape

  • 6.1. Point of Care Infectious Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Point of Care Infectious Disease Testing Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Lateral Flow Immunoassay
    • 7.1.3. Agglutination Test
    • 7.1.4. Flow-through test/Immunoconcentration Assay
    • 7.1.5. Molecular Diagnostics
    • 7.1.6. Others

8. Point of Care Infectious Disease Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. HIV POC
    • 8.1.3. Clostridium Difficile POC
    • 8.1.4. HBV POC
    • 8.1.5. Pneumonia Or Streptococcus Associated Infections
    • 8.1.6. Respiratory Syncytial Virus (RSV) POC
    • 8.1.7. HPV POC
    • 8.1.8. Influenza/Flu POC
    • 8.1.9. HCV POC
    • 8.1.10. MRSA POC
    • 8.1.11. TB & Drug-resistant TB POC
    • 8.1.12. HSV POC
    • 8.1.13. COVID-19
    • 8.1.14. Other

9. Point of Care Infectious Disease Testing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Home and Self Testing
    • 9.1.5. Assisted Living Healthcare Facilities
    • 9.1.6. Laboratory

10. Point of Care Infectious Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Point of Care Infectious Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Point of Care Infectious Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Point of Care Infectious Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Point of Care Infectious Disease Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Point of Care Infectious Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point of Care Infectious Disease Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Siemens Healthineers
    • 11.2.3. Becton, Dickinson & Company
    • 11.2.4. Abbott
    • 11.2.5. Thermo Fisher Scientific Inc
    • 11.2.6. Chembio Diagnostics Inc.
    • 11.2.7. Trinity Biotech
    • 11.2.8. Cardinal Health
    • 11.2.9. Quest Diagnostics Incorporated
    • 11.2.10. Bio-Rad Laboratories Inc.
    • 11.2.11. bioMerieux SA
    • 11.2.12. Sight Diagnostics Ltd.
    • 11.2.13. Gene POC
    • 11.2.14. Trivitron Healthcare
    • 11.2.15. OJ-Bio Ltd.
    • 11.2.16. Ortho-Clinical Diagnostics.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us